CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|9|1195-1207

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.9, 2015-09, pp. : 1195-1207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 1, 2018-01 ,pp. : 136-144

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 46, Iss. 11, 2016-10 ,pp. : 1099-1106

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 1958-1964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre‐transplant cytomegalovirus antibody titers predict outcome?

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 4, 2015-04 ,pp. : 539-546

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genomic Profiles and Predictors of Early Allograft Dysfunction After Human Liver Transplantation

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 6, 2015-06 ,pp. : 1605-1614

John Wiley & Sons Inc

Access to resources Recommend Favorite